217 related articles for article (PubMed ID: 34730794)
1. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
Esen I; Jiemy WF; van Sleen Y; Bijzet J; de Jong DM; Nienhuis PH; Slart RHJA; Heeringa P; Boots AMH; Brouwer E
Rheumatology (Oxford); 2022 Jul; 61(7):3060-3070. PubMed ID: 34730794
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase-associated inflammation in patients with giant cell arteritis. Evaluation by histology and 11C-donepezil PET/CT.
Therkildsen P; Nielsen BD; Hansen IT; Keller KK; Steiniche T; Gormsen LC; Borghammer P; Hauge EM
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):20-25. PubMed ID: 31162030
[TBL] [Abstract][Full Text] [Related]
3. Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.
Nielsen BD; Hansen IT; Kramer S; Haraldsen A; Hjorthaug K; Bogsrud TV; Ejlersen JA; Stolle LB; Keller KK; Therkildsen P; Hauge EM; Gormsen LC
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):184-193. PubMed ID: 30066157
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of
Hay B; Mariano-Goulart D; Bourdon A; Benkiran M; Vauchot F; De Verbizier D; Ben Bouallègue F
Ann Nucl Med; 2019 Jul; 33(7):512-520. PubMed ID: 30976984
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG
J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549
[TBL] [Abstract][Full Text] [Related]
6. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
[TBL] [Abstract][Full Text] [Related]
7. [18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.
Imfeld S; Rottenburger C; Schegk E; Aschwanden M; Juengling F; Staub D; Recher M; Kyburz D; Berger CT; Daikeler T
Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):933-940. PubMed ID: 29126277
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.
Nielsen BD; Hansen IT; Keller KK; Therkildsen P; Gormsen LC; Hauge EM
Rheumatology (Oxford); 2020 Aug; 59(8):2062-2073. PubMed ID: 31808526
[TBL] [Abstract][Full Text] [Related]
9. Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization.
Stellingwerff MD; Brouwer E; Lensen KDF; Rutgers A; Arends S; van der Geest KSM; Glaudemans AWJM; Slart RHJA
Medicine (Baltimore); 2015 Sep; 94(37):e1542. PubMed ID: 26376404
[TBL] [Abstract][Full Text] [Related]
10. Imaging giant cell arteritis and Aortitis in contrast enhanced 18F-FDG PET/CT: Which imaging score correlates best with laboratory inflammation markers?
Olthof SC; Krumm P; Henes J; Nikolaou K; la Fougère C; Pfannenberg C; Schwenzer N
Eur J Radiol; 2018 Feb; 99():94-102. PubMed ID: 29362158
[TBL] [Abstract][Full Text] [Related]
11. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis.
Soussan M; Nicolas P; Schramm C; Katsahian S; Pop G; Fain O; Mekinian A
Medicine (Baltimore); 2015 Apr; 94(14):e622. PubMed ID: 25860208
[TBL] [Abstract][Full Text] [Related]
12. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
[TBL] [Abstract][Full Text] [Related]
13. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio.
Hautzel H; Sander O; Heinzel A; Schneider M; Müller HW
J Nucl Med; 2008 Jul; 49(7):1107-13. PubMed ID: 18552151
[TBL] [Abstract][Full Text] [Related]
14. Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis.
Sammel AM; Xue M; Karsten E; Little CB; Smith S; Nguyen K; Laurent R
Int J Rheum Dis; 2021 Jun; 24(6):781-788. PubMed ID: 33847438
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.
Prieto-González S; Depetris M; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Corbera-Bellata M; Planas-Rigol E; Alba MA; Hernández-Rodríguez J; Grau JM; Lomeña F; Cid MC
Ann Rheum Dis; 2014 Jul; 73(7):1388-92. PubMed ID: 24665112
[TBL] [Abstract][Full Text] [Related]
16. [18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?
Imfeld S; Aschwanden M; Rottenburger C; Schegk E; Berger CT; Staub D; Daikeler T
Rheumatology (Oxford); 2020 Apr; 59(4):772-778. PubMed ID: 31436837
[TBL] [Abstract][Full Text] [Related]
17. Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis.
Nienhuis PH; Sandovici M; Glaudemans AW; Slart RH; Brouwer E
Semin Arthritis Rheum; 2020 Aug; 50(4):616-623. PubMed ID: 32502725
[TBL] [Abstract][Full Text] [Related]
18. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
[TBL] [Abstract][Full Text] [Related]
19. A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 Axis.
van Sleen Y; Jiemy WF; Pringle S; van der Geest KSM; Abdulahad WH; Sandovici M; Brouwer E; Heeringa P; Boots AMH
Arthritis Rheumatol; 2021 Dec; 73(12):2327-2337. PubMed ID: 34105308
[TBL] [Abstract][Full Text] [Related]
20. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
Quinn KA; Dashora H; Novakovich E; Ahlman MA; Grayson PC
Rheumatology (Oxford); 2021 Sep; 60(9):4384-4389. PubMed ID: 33369678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
